Optical Coherence Tomography (OCT) Market Size, Share, Trends, & Industry Analysis Report

Overview

The global optical coherence tomography (OCT) market size was valued at USD 1.28 billion in 2024, growing at a CAGR of 13.7% from 2025–2034. Key factors driving demand include increasing awareness of early disease diagnosis and the importance of regular monitoring for chronic conditions, rising healthcare expenditure and improved reimbursement policies, advancements in optical coherence tomography (OCT) technology, and rapidly aging global population.

Key Insights

• The time domain optical coherence tomography segment held a 42.02% revenue share in 2024, driven by cost-efficiency and broad clinical adoption.
• The doppler OCT segment is projected to grow at a 14.6% CAGR, fueled by its ability to simultaneously image tissue structure and blood flow.
• The ophthalmology segment captured 71.02% revenue share in 2024 due to its critical role in diagnosing and monitoring retinal diseases and glaucoma.
• North America held a 37.54% global market share in 2024, attributed to advanced healthcare infrastructure and high adoption of innovative diagnostic technologies.
• The U.S. accounted for 27.78% of the North American market in 2024, reflecting strong integration of OCT in ophthalmology and cardiology practices.
• The Asia Pacific market is projected to grow at a 14.3% CAGR from 2025–2034, owing to rising healthcare investment and increasing prevalence of chronic conditions.
• China’s market generated USD 130.1 million in revenue in 2024, driven by healthcare modernization and growing demand for advanced diagnostic solutions.

Industry Dynamics

• Technological advancements in OCT, including swept-source and portable systems, are enhancing diagnostic precision, speed, and accessibility across medical specialties.
• A rapidly aging global population is increasing demand for OCT, as age is a key risk factor for chronic eye diseases like glaucoma and macular degeneration.
• High system costs and limited reimbursement policies restrict broader adoption, especially in cost-sensitive and emerging markets.
• Expansion into non-ophthalmic applications like cardiology and dermatology opens new revenue streams and diversifies the customer base.

Market Statistics

• 2024 Market Size: USD 1.28 billion
• 2034 Projected Market Size: USD 4.65 billion
• CAGR (2025-2034): 13.7%
• North America: Largest market in 2024

AI Impact on Optical Coherence Tomography (OCT) Market

• AI automates image analysis, drastically reducing interpretation time and minimizing diagnostic errors for more efficient and accurate patient assessments.
• It enables earlier and more precise detection of subtle disease patterns, transforming OCT from imaging tool to predictive diagnostic aid.
• AI-powered software allows integration with telehealth platforms, making expert-level retinal screening accessible in remote or underserved areas.
• These intelligent systems streamline clinical workflows, lowering operational costs and allowing ophthalmologists to focus on complex cases and treatment.

Optical coherence tomography (OCT) is a non-invasive imaging technique that provides high-resolution cross-sectional images of biological tissues, widely used in ophthalmology and other medical fields.

The OCT market is driven by the increasing awareness of early disease diagnosis, as timely detection plays a critical role in preventing the progression of vision-related disorders and systemic conditions. According to an October 2023 World Health Organization report, preventable or untreated vision impairments affect 1 billion of the 2.2 billion people globally living with sight challenges. OCT is increasingly recognized as a vital diagnostic tool for identifying retinal and vascular abnormalities at an early stage, with healthcare systems focusing on preventive care. The rising demand for advanced diagnostic technologies is driving market adoption, as OCT enables clinicians to make informed treatment decisions and enhance patient outcomes.

The OCT market is further driven by the growing importance of regular monitoring for chronic conditions, particularly eye-related disorders such as glaucoma, age-related macular degeneration, and diabetic retinopathy. OCT provides a reliable and precise method for tracking disease progression and treatment efficacy over time, as chronic diseases often require continuous evaluation. Regular monitoring supports better disease management and reduces the risk of severe complications by allowing for timely interventions. Additionally, the expanding role of OCT in routine patient care reflects the broader trend toward long-term health management, further accelerating its integration into clinical practices.

Drivers & Opportunities

Advancement in Optical Coherence Tomography Technology: Advancements in optical coherence tomography (OCT) technology are boosting growth opportunities as they enhance diagnostic precision, imaging speed, and accessibility across various medical specialties. Innovations such as swept-source OCT, OCT angiography, and portable OCT devices are enabling clinicians to capture deeper, more detailed images with improved clarity and faster processing. For instance, in February 2024, ARPA-H launched the PIC-OCT project to develop faster, more affordable photonic chip-based eye scanners. This aims to address current limitations of high costs and motion sensitivity in traditional OCT diagnostics. These advancements enhance the detection of complex retinal and vascular conditions, and also expand the applications of OCT beyond ophthalmology into cardiology, dermatology, and oncology. Additionally, it supports minimally invasive diagnostics as technology continues to evolve. It also facilitates integration with digital platforms and artificial intelligence, further strengthening its role as a key tool in modern healthcare practices.

Rapidly Aging Global Population: The rapidly aging global population is also increasing the need for OCT, as age is a primary risk factor for several chronic eye conditions, such as glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration. The prevalence of vision-related disorders is rising, creating a greater demand for advanced diagnostic solutions like OCT, with the elderly demographic expanding worldwide. According to a report released by the World Health Organization in October 2024, by 2030, one in six people will be over 60 years old. This demographic is projected to double to 2.1 billion by 2050, with the number of people over 80 expected to triple to 426 million by that year. Older patients often require regular monitoring and early detection to manage progressive conditions effectively, making OCT a vital tool in geriatric care. This demographic trend highlights the growing reliance on OCT for preventive screening, disease management, and treatment planning, thereby contributing to sustained market growth.

Segmental Insights

Technology Analysis

Based on technology, the segmentation includes time domain optical coherence tomography (TDOCT), frequency domain optical coherence tomography (FD-OCT), spatially encoded frequency domain optical coherence tomography. The time domain optical coherence tomography (TDOCT) segment accounted for 42.02% revenue share in 2024 driven by its early adoption, cost-effectiveness, and wide availability across healthcare facilities. Although it provides relatively lower resolution and slower image acquisition compared to newer technologies, TDOCT remains a preferred option in many clinical settings where affordability and accessibility are major considerations. Its established presence in ophthalmology practices and diagnostic centers continues to drive usage, particularly in regions with limited access to advanced imaging systems.

The spatially encoded frequency domain optical coherence tomography segment is expected to witness fastest growth at a CAGR of 14.3% during the forecast period due to its ability to deliver higher imaging speed, superior resolution, and three-dimensional visualization of tissues. This technology enables faster scans with enhanced accuracy, which significantly improves the diagnosis and monitoring of complex conditions. Furthermore, its compatibility with advanced imaging systems and integration with artificial intelligence-driven analysis make it increasingly relevant in precision medicine. The growing preference for advanced solutions that improve both patient outcomes and clinician efficiency is driving the adoption of spatially encoded FD-OCT.

Type Analysis

In terms of type, the segmentation includes catheter based OCT devices, doppler OCT devices, handheld OCT devices, tabletop OCT devices. The catheter based OCT devices segment dominated the revenue share with 18.72% in 2024 due to their extensive use in cardiovascular diagnostics, particularly for intravascular imaging and intervention planning. These devices enable clinicians to capture detailed images of coronary arteries, facilitating accurate assessment of plaque morphology and stent placement. Their proven role in enhancing clinical decision-making in interventional cardiology has established them as a critical tool, driving their widespread adoption in specialized healthcare facilities.

The doppler OCT devices segment is expected to witness fastest growth during the forecast period at a CAGR of 14.6% during the forecast period driven by their ability to measure tissue structure and blood flow dynamics simultaneously. This dual capability enables comprehensive evaluation in ophthalmology, oncology, and vascular studies, providing clinicians with a powerful tool for early disease detection and monitoring. Moreover, advancements in Doppler OCT technology have further improved imaging speed and sensitivity, making it an attractive choice for expanding clinical applications. The growing demand for multifunctional diagnostic tools is propelling the uptake of Doppler OCT devices.

Application Analysis

The segmentation based on application includes ophthalmology, cardiovascular, oncology, dermatology, other applications. The ophthalmology segment captured 71.02% revenue share in 2024 attributed to the widespread use of OCT in diagnosing and monitoring retinal diseases, glaucoma, and macular degeneration. OCT has become an indispensable tool in eye care, enabling precise imaging of retinal layers for early detection and treatment planning as vision-related disorders remain a major public health concern. Its non-invasive nature, quick imaging process, and ability to track disease progression have solidified its dominant role in ophthalmic applications.

The oncology segment is expected to witness rapid growth at a 14.5% CAGR during the forecast period driven by its expanding role in cancer diagnostics, particularly in identifying tumor margins and assessing tissue microstructures. OCT offers real-time imaging that supports minimally invasive surgery procedures, enhancing the accuracy of biopsies and treatment outcomes. OCT is gaining traction as a complementary tool in oncology, supporting better visualization and reducing diagnostic uncertainties with the increasing focus on early cancer detection and precision oncology.

Regional Analysis

North America optical coherence tomography (OCT) market accounted for 37.54 % of global market share in 2024. This dominance is attributed to the strong presence of advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, a well-established research and development ecosystem, and a focus on early disease detection. A May 2025 report by the Centers for Disease Control and Prevention indicates that vision and eye problems affect 90 million Americans aged 40 and older, representing more than three out of every five individuals in this age group, highlighting the importance of early disease detection. The region’s focus on early disease detection and preventive healthcare further drives the growth of OCT, supported by the active participation of major industry players and academic institutions.

U.S. Optical Coherence Tomography (OCT) Market Insight

U.S. held 27.78% market share in North America optical coherence tomography (OCT) landscape in 2024 due to the widespread adoption of advanced diagnostic technologies and strong integration of OCT in ophthalmology and cardiology practices. The country benefits from a highly developed healthcare infrastructure, coupled with strong investments in research and clinical innovation. Additionally, the presence of leading OCT manufacturers and academic institutions drives continuous product development and early adoption of next-generation optical imaging systems.

Asia Pacific Optical Coherence Tomography (OCT) Market

The market in Asia Pacific is projected to grow at a CAGR of 14.3% from 2025-2034, owing to increasing healthcare investments, rising prevalence of chronic eye and cardiovascular conditions, and expanding access to advanced diagnostic technologies. Rapid urbanization, growing awareness of preventive care, and government support for modernizing healthcare systems are accelerating the adoption of OCT in clinical settings. The region’s large patient base and growing demand for cost-effective, high-quality diagnostic solutions position it as a hub for growth in the OCT market.

China Optical Coherence Tomography (OCT) Market Overview

The market in China is expanding with USD 130.1 million revenue in 2024 driven by rising healthcare modernization efforts and increasing demand for advanced diagnostic solutions in urban areas. Government support for improving ophthalmic care, along with a growing patient base affected by chronic eye and cardiovascular diseases, is driving the adoption of OCT. Furthermore, local manufacturing capabilities and strategic collaborations are helping make OCT technologies more accessible and affordable across various healthcare facilities in the country.

Europe Optical Coherence Tomography (OCT) Market

The optical coherence tomography (OCT) landscape in Europe captured 23.52% share of the market in 2024 driven by strong regulatory support for medical device innovation and the increasing focus on advanced diagnostic imaging in healthcare systems. The region benefits from a robust network of healthcare providers and research institutions that actively integrate OCT into routine clinical practices. Additionally, the growing focus on precision medicine, with the increasing adoption in ophthalmology and cardiovascular care, is further supporting the steady expansion of OCT across European healthcare markets.

 Germany Optical Coherence Tomography (OCT) Market

The Germany market is driven by a strong focus on precision diagnostics and the integration of advanced imaging tools within its well-structured healthcare system. High awareness among healthcare providers and patients about the benefits of early disease detection has accelerated the adoption of OCT in ophthalmology and oncology. In addition, Germany’s position as a hub for medical research and innovation enables continuous advancements in OCT applications, further strengthening its role in the country’s clinical landscape.

Key Players & Competitive Analysis Report

The optical coherence tomography (OCT) landscape is characterized by intense competition, driven by technological advancement and strategic investments from key players. Competitive intelligence and strategy reveal that industry leaders are focusing on revenue growth through innovation in swept-source and portable medical devices, expanding beyond developed markets into emerging markets with high latent demand and opportunities. Vendor assessment indicates a push toward integrating AI for enhanced diagnostic precision, creating new revenue opportunity and strengthening sustainable value chains. Expert's insight suggests that economic and geopolitical shifts and supply chain disruptions remain critical challenges. However, growth projections remain strong, fueled by an aging population and increasing adoption in cardiology and oncology. Future development strategies are centered on expansion opportunities in untapped emerging market segments, leveraging region-wise market size data to guide competitive positioning and commercial success.

Major companies operating in the optical coherence tomography (OCT) industry include Abbott Laboratories, Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Koninklijke Philips, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Thorlabs Inc., and Topcon Medical Systems Inc.

Key Players

• Abbott Laboratories
• Agfa Healthcare
• Carl Zeiss Meditec AG
• Heidelberg Engineering GmbH
• Koninklijke Phillips
• Michelson Diagnostics
• Novacam Technologies Inc.
• OPTOPOL Technology S.A
• Thorlabs Inc.
• Topcon Medical Systems Inc.

Industry Developments

•  October 2024: Siloton secured approximately USD 1.09 million in new funding to advance its Akepa optical coherence tomography (OCT) chip technology. This investment will support the development of a research-focused version of the device, with the potential to contribute to blindness prevention efforts.
• May 2024, palleos healthcare GmbH and OCT Clinical GmbH merged to form a unified contract research organization. This combines their regional expertise across Western, Central, and Eastern Europe, enhancing patient recruitment capabilities across a broad geographic base.

Optical Coherence Tomography (OCT) Market Segmentation

By Technology Outlook (Revenue, USD Billion, 2020–2034)

• Time Domain Optical Coherence Tomography (TDOCT)
• Frequency Domain Optical Coherence Tomography (FD-OCT)
• Spatially Encoded Frequency Domain Optical Coherence Tomography
  • Fourier Domain Optical Coherence Tomography (FDOCT)
  • Spectral Domain Optical Coherence Tomography (SDOCT)

By Type Outlook (Revenue, USD Billion, 2020–2034)

• Catheter based OCT devices
• Doppler OCT devices
• Handheld OCT devices
• Tabletop OCT devices

By Application Outlook (Revenue, USD Billion, 2020–2034)

• Ophthalmology
• Cardiovascular
• Oncology
• Dermatology
• Other Applications

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Optical Coherence Tomography (OCT) Market Report Scope